ICG 001
Tocris Bioscience, part of Bio-Techne | Catalog # 4505
Inhibits TCF/β-catenin-mediated transcription
Key Product Details
Description
Inhibits TCF/β-catenin-mediated transcription
Product Description
ICG 001 is an inhibitor of TCF/β-catenin-mediated transcription. Selectively inhibits β-catenin/CBP interaction; displays no effect on β-catenin/p300 interaction. Exhibits growth inhibitory effects in colon carcinoma cell lines (SW480 and HCT-116 cells); also displays efficacy in Min mouse and nude mouse SW620 xenograft models.Product Specifications
Molecular Weight
548.63
Formula
C33H32N4O4
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
(6S,9aS)-Hexahydro-6-[(4-hydroxyphenyl)methyl]-8-(1-naphthalenylmethyl)-4,7-dioxo-N-(phenylmethyl)-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide
CAS Number
780757-88-2
PubChem ID
11238147
InChI Key
HQWTUOLCGKIECB-XZWHSSHBSA-N
SMILES
O=C1CCN(C(NCC5=CC=CC=C5)=O)[C@]2([H])N1[C@@H](CC6=CC=C(O)C=C6)C(N(CC3=C(C=CC=C4)C4=CC=C3)C2)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 54.86 | 100 | |
| Ethanol | 27.43 | 50 |
Preparing Stock Solutions
for ICG 001
The following data is based on the product molecular weight 548.63
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.82 mL | 9.11 mL | 18.23 mL |
| 5 mM | 0.36 mL | 1.82 mL | 3.65 mL |
| 10 mM | 0.18 mL | 0.91 mL | 1.82 mL |
| 50 mM | 0.04 mL | 0.18 mL | 0.36 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- De Sousa Targeting wnt signaling in colon cancer stem cells. Clin.Cancer Res. 2011 PMID: 21159886
- Zhou Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-respo J.Biol.Chem. 2012 PMID: 22241478
- Emami A small molecule inhibitor of β-catenin/CREB-binding protein transcription. Proc.Natl.Acad.Sci.USA 2004 PMID: 15314234
Product Specific Notices for ICG 001
For research use only
Loading...
Loading...
Loading...